Integral Diagnostics (ASX:IDX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Integral Diagnostics (ASX:IDX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Application for quotation of securities - IDX
Notification regarding unquoted securities - IDX
2026 Notice of Annual General Meeting
Update - Dividend/Distribution - IDX
Integral Diagnostics confirms dividend exchange rate and DRP price
Ceasing to be a substantial holder from WAM/WAX/WMI
Change in substantial holding
Change in substantial holding from CGF
Notification of cessation of securities - IDX
Notification regarding unquoted securities - IDX
Notification of cessation of securities - IDX
Notification regarding unquoted securities - IDX
Change of Director's Interest Notice - Ingrid Player NED
Change of Director's Interest Notice - Jason Martinez CEO
Dividend/Distribution - IDX
Integral Diagnostics declares fully franked 6-cent dividend with DRP for FY2026 H1
FY26 Appendix 4G
FY26 Full Year Investor Presentation
IDX delivers strong FY26 results with 25.6% revenue growth and 30.3% EBITDA increase, exceeding merger synergy targets
FY26 Full Year Results Announcement
Integral Diagnostics posts strong FY26 results with 25.6% revenue growth and 50% NPAT increase
FY26 Annual Report
Integral Diagnostics reports strong FY26 results with 26% revenue growth, $22M profit, and 9.3 cents dividend
2026 Annual General Meeting Date
Change in substantial holding
Preliminary FY26 Results and Appointment of New CFO
Integral Diagnostics reports strong FY26 preliminary results and appoints new CFO Jenny Martin
Initial Director's Interest Notice - Jason Martinez
Final Director's Interest Notice - Dr Ian Kadish
Start for New Managing Director and Chief Executive Officer
Integral Diagnostics appoints Jason Martinez as new CEO, succeeding retiring Ian Kadish
Re-issued IDX FY26 Results Conference Call
IDX FY26 Results Conference Call